July 12, 2019
Bio-Labs has adapted one of the oldest public park and fountain in the heart of Islamabad located in the E-7 Sector/Margalla Road vicinity namely, Gulistan-e- Fatima Park, established in the early years of the city.
March 25, 2019
New therapeutic products launched including MyVan injection (Vancomycin), Life Tablets (Leflunomide) and P-Trand tablets (Tramadol+Paracetamol)
March 11, 2019
Bio-Labs continues to bring innovative therapeutic solutions in the field of Oncology and Breast Cancer through launch of Letfer Tablets (Letrozole)
February 20, 2019
Pharmacy and Poison Board, Kenya (PPB) successfully culminated audit of Bio-Labs manufacturing facility for re-issuance of Good Manufacturing Practices (GMP) certificate.
January 10, 2019
Proudly launching new products in the field of Skincare/Dermatology. C-Mycin cream (Clindamycin) , Bio Eflorin cream (Eflornithine) , Eslod tablets (Desloratadine) , Flucin cream (Fluocinolone Acetonide), and Flacet N cream (Fluocinolone/Neomycin).
January 15, 2018
Several new and novel lifesaving drugs are launched in the domestic and international markets including TIGABIO Injection ( Tigecycline USP ) and BIOROLAC Ampoule (Ketorolac Tromethamine) and BIOPRIM Injection (Cefepime HCl)
November 30, 2017
Achievement of GMP compliance certificate from FDA Philippines, based on PIC/S Guidelines
August 16, 2017
Drug Regulatory Authority of Pakistan (DRAP) grants approval of veterinary injectable facilities including penicillin liquid, penicillin powder and general liquid injections for veterinary use.
May 20, 2017
Ministry of Public Health & Population, Republic of Yemen successfully conducts a panel inspection of our manufacturing facility and grants GMP/Registration certificate for export of human therapeutic drugs to the Republic of Yemen
January 15, 2017
Bio-Labs establishes a dedicated penicillin facility for manufacturing of oral dosage forms for Animal Health products
October 25, 2016
Bio-Labs received another achievement milestone in form of an award by the Rawalpindi Chamber of Commerce...
March 2, 2016
Bio-Labs expands international operations into CIS countries by commencing regulatory registrations in several therapeutic categories.
December 10, 2015
A new range of dermatology products under the brand name of BUSID CREAM are launched including Fusidic Acid, Betamethasone & Hydrocortisone for better skin infections treatment.
October 12, 2015
Bio-Labs launches BIO-D3, a new range of Vitamin D3 products including dosage forms in liquid ampoules, tablets and drops...
May 12, 2015
Kenya Pharmacy & Poison Board (PPB) grants Good Manufacturing Practices license to Bio-Labs after successful plant inspection allowing further market expansion in the African continent.
June 5, 2014
Bio-Labs recently launched several new products including liquid ampoules such as Iron Sucrose and Vitamin D3 (Cholecalciferol) being manufactured in its new manufacturing facility.
July 15, 2013
Bio-Labs has recently received another accolade of being ranked number 12 in the fastest growing companies in the region known as ARABIA 500 by Harvard University […]
March 10, 2013
Bio-Labs has the honor of being ranked 25th fastest growing company in Pakistan by Harvard Business School Michael Porter’s ALL WORLD NETWORK. For details, please visit: […]
February 15, 2013
Bio-Labs successfully implements SAP business management software technology integrating all core business...
March 5, 2012
New product launch of IROPAS Chewable Tablets and Sugar Free Syrup (Iron Protein Succinylate)
October 2, 2011
Newly developed manufacturing facility for production of sterile liquid ampoules, infusions, and lyophilized injections is approved by MOH, Pakistan